Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Study Switching HIV-1 Infected Patients With an Undetectable Viral Load on a First Protease Inhibitor-Based Regimen to an Efavirenz-Based Regimen

ClinicalTrials.gov ID: NCT00135382

Public ClinicalTrials.gov record NCT00135382. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 14, 2026, 11:32 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Study Switching HIV-1 Infected Patients With an Undetectable Viral Load on a First Protease Inhibitor-Based Regimen to an Efavirenz-Based Regimen

Study identification

NCT ID
NCT00135382
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
254 participants

Conditions and interventions

Conditions

Interventions

  • Epivir Drug
  • Sustiva Drug
  • Videx EC Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2002
Primary completion
Sep 30, 2005
Completion
Sep 30, 2005
Last update posted
Feb 16, 2010

2002 – 2005

United States locations

U.S. sites
46
U.S. states
17
U.S. cities
46
Facility City State ZIP Site status
Local Institution Little Rock Arkansas
Local Institution Beverly Hills California
Local Institution Fountain Valley California
Local Institution Long Beach California
Local Institution Los Angeles California
Local Institution San Diego California
Local Institution San Francisco California
Local Institution Tarzana California
Local Institution West Hollywood California
Local Institution Denver Colorado
Local Institution Norwalk Connecticut
Local Institution Washington D.C. District of Columbia
Local Institution Atlantis Florida
Local Institution Daytona Beach Florida
Local Institution Fort Lauderdale Florida
Local Institution Jacksonville Florida
Local Institution Miami Florida
Local Institution Miami Beach Florida
Local Institution North Miami Florida
Local Institution Orlando Florida
Local Institution Plantation Florida
Local Institution Safety Harbor Florida
Local Institution South Miami Florida
Local Institution Tampa Florida
Local Institution Atlanta Georgia
Local Institution Decatur Georgia
Local Institution Chicago Illinois
Local Institution Boston Massachusetts
Local Institution Springfield Massachusetts
Local Institution Kansas City Missouri
Local Institution St Louis Missouri
Local Institution East Orange New Jersey
Local Institution Newark New Jersey
Local Institution Union New Jersey
Local Institution Brooklyn New York
Local Institution Manhasset New York
Local Institution Mount Vernon New York
Local Institution New York New York
Local Institution Stony Brook New York
Local Institution Valhalla New York
Local Institution Philadelphia Pennsylvania
Local Institution Columbia South Carolina
Local Institution Austin Texas
Local Institution Dallas Texas
Local Institution Hampton Virginia
Local Institution Milwaukee Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00135382, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 16, 2010 · Synced May 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00135382 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →